Clinical Trial Update: Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated radiation therapy with combination chemotherapy and amifostine for head and neck cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary
• Head and Neck Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: University of Miami | Conditions: Carcinoma of Unknown Primary, Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED